Dr. Amanda Weyerbacher Elevated to Executive VP at inThought Research Inc. to Enhance Operational Expertise

inThought Research Announces Dr. Amanda Weyerbacher's Promotion

Orlando, Florida—On March 31, 2026, inThought Research Inc., a prominent name in the life sciences industry, revealed the promotion of Dr. Amanda Weyerbacher to the position of Executive Vice President of Projects and Operations. Dr. Weyerbacher's new role will focus on enhancing project execution and enforcing operational standards, ensuring that clients receive top-notch decision support, a hallmark of inThought's services.

Dr. Weyerbacher has been instrumental within inThought since her arrival in 2015, progressively advancing from the Director of Research to now overseeing project execution and operational rigor. Under her guidance, projects spanning oncology, immunology, and respiratory diseases have thrived, showcasing her extensive expertise and dedication to the field. Prior to joining inThought, she sharpened her skills as a Senior Scientist at L'Oréal, further enriching her background in the life sciences sector.

In her new capacity, Dr. Weyerbacher aims to refine project quality and compliance, collaborating closely with project leaders to maintain inThought's commitment to excellence. President Ben Weintraub remarked, "Dr. Weyerbacher is critical to our ability to effectively execute opportunity assessments, licensing due diligence, launch planning, competitive positioning, life cycle management, and various strategic projects that demand agility and expertise."

A graduate of Skidmore College, Dr. Weyerbacher holds a PhD in Pharmacology from Weill Cornell Medical College. Her academic and professional journey has equipped her with the tools necessary to lead the innovative and dynamic environments she will now oversee. Expressing her enthusiasm about her new role, she stated, "I am excited to empower our extraordinary analysts with the resources they need to provide exceptional strategic advice to our clients."

inThought Research is recognized for its sophisticated approach to empowering biopharmaceutical leaders with comprehensive strategic insights. The company merges quick financial insights akin to Wall Street strategies with in-depth scientific and medical knowledge, alongside advanced AI analytics, to navigate drug development's complexities. This multidisciplinary methodology integrates clinical data with market analytics and stakeholder perspectives, ensuring that clients make informed decisions based on accurate data.

Additionally, through inThought Labs, the company harmonizes cutting-edge technology with the expertise of its subject matter professionals to transform intricate data into actionable intelligence. This commitment to blending technology and expertise is what sets inThought apart as a thought leader in the realm of life sciences.

For more updates and details on inThought Research and its services, visit their official website at www.inthought.com.

For media inquiries, please reach out to Doug Foster, Chief Operating Officer, at (508) 414-9819 or via email at [email protected].

As inThought continues to evolve under the guidance of visionary leaders like Dr. Weyerbacher, their dedication to quality assurance and strategic insight in the life sciences industry will undoubtedly shape the future of decision support for years to come.